Sr. Clinical Research Associate - Early Phase Studies

Thermo Fisher Scientific•Las Vegas, NV

About The Position

The Senior Clinical Research Associate (CRA) supports Early Development studies, primarily Phase I and clinical pharmacology trials. The role independently performs and coordinates clinical monitoring and site management, conducting remote and on-site visits to assess protocol compliance, participant safety, data integrity, and regulatory adherence. The position primarily supports an investigational site in Las Vegas, Nevada; candidates must be based in the Las Vegas area. Travel to other investigational sites may be required according to study and business needs, including overnight travel. The CRA serves as a site processes specialist, ensuring trials follow approved protocols, ICH-GCP guidelines, applicable regulations, and standard operating procedures while protecting participant rights, safety, and well-being. The role supports complex early-phase research, including intensive safety assessments, dose escalation, PK/PD sampling, and time-sensitive study procedures. It also promotes audit readiness and collaborative relationships with sites, sponsors, and cross-functional study teams.

Requirements

  • Bachelor's degree in life sciences, nursing, pharmacy, or a related medical/scientific discipline, or an equivalent combination of education, training, and relevant experience.
  • 3–5+ years of independent clinical monitoring experience as a CRA, including site qualification, initiation, interim monitoring, and close-out visits.
  • Strong medical and scientific knowledge, including the ability to independently review and interpret source documentation such as medical histories, laboratory results, concomitant medications, adverse events, and eligibility criteria.
  • Must be based in the Las Vegas, Nevada area and able to travel to additional locations as needed.
  • Valid driver's license where applicable.
  • Thorough understanding of ICH-GCP, applicable regulations, SOPs, and clinical monitoring requirements.
  • Strong understanding of early-phase trial conduct, including dose escalation, intensive safety monitoring, stopping criteria, dosing procedures, PK/PD sampling, and high-volume source data review.
  • Ability to independently manage monitoring activities, prioritize competing requirements, and exercise sound clinical judgment.
  • Critical thinking, risk assessment, root cause analysis, and problem-solving skills, including appropriate issue escalation.
  • Understanding of risk-based monitoring concepts and processes.
  • Excellent written and verbal communication skills and ability to collaborate with sites, medical personnel, sponsors, and cross-functional teams.
  • Strong interpersonal, relationship-management, organizational, and attention-to-detail skills; ability to manage priorities in time-sensitive environments.
  • Ability to work independently with minimal oversight and contribute effectively to collaborative teams.
  • Flexibility and adaptability to changing study priorities and operational needs.
  • Proficiency in Microsoft Office and ability to learn and use CTMS and other relevant software.
  • Strong English language and grammar skills.

Nice To Haves

  • Previous Phase I or Early Development clinical monitoring experience, particularly with complex early-phase or clinical pharmacology studies.
  • Approximately 3+ years of Phase I monitoring experience is ideal; candidates with less Phase I experience and substantial hands-on exposure to complex early-phase protocols may also be considered.
  • Direct monitoring experience with First-in-Human, Single Ascending Dose, and Multiple Ascending Dose studies.
  • Experience with PK/PD, Drug-Drug Interaction, Food Effect, or Bioavailability/Bioequivalence studies.
  • Experience monitoring QT/QTc, ADME/mass balance, renal impairment, hepatic impairment, MASH, or other specialty-population studies.
  • Experience with complex routes of administration, including intravenous, subcutaneous, or other injectable therapies.
  • Monitoring experience within dedicated Phase I or clinical pharmacology units.
  • Experience as a Lead CRA, mentoring junior CRAs, or taking on additional senior-level monitoring responsibilities.
  • Experience working independently in lean or cross-functional project structures, including studies without a designated Clinical Trial Manager.

Responsibilities

  • Independently monitor investigational sites using a risk-based approach, identifying compliance gaps and risks and supporting corrective and preventive actions.
  • Conduct site qualification, site initiation, interim monitoring, and close-out visits in accordance with monitoring plans, protocols, and regulatory requirements.
  • Support Phase I and Early Development studies, including First-in-Human, Single Ascending Dose, Multiple Ascending Dose, and PK/PD studies.
  • Monitor participant safety, dose escalation, stopping criteria, dosing requirements, time-sensitive sample collection, and clinical data review.
  • Perform source data review, source data verification, and case report form review, as applicable.
  • Review medical histories, laboratory results, concomitant medications, adverse events, eligibility assessments, and other clinical documentation.
  • Assess investigational product accountability through physical inventory and records review.
  • Identify, document, and escalate safety concerns, protocol deviations, data discrepancies, and study risks; partner with sites and project teams on resolution and follow-up.
  • Prepare timely and accurate monitoring reports and follow-up letters.
  • Communicate regularly with investigational sites between visits regarding protocol adherence, outstanding issues, and data entry.
  • Participate in investigator meetings and collaborate on site identification, qualification, initiation, monitoring, and close-out activities.
  • Ensure essential documents are complete, accurate, and maintained in accordance with ICH-GCP, applicable regulations, and project requirements; conduct on-site file reviews as required.
  • Maintain study tracking and monitoring records in CTMS and other applicable platforms.
  • Facilitate communication among sites, sponsors, and cross-functional teams, particularly about time-sensitive activities and emerging risks.
  • Support audit and inspection readiness and respond to sponsor, company, and regulatory requirements.
  • Complete administrative responsibilities such as expense reports and timesheets.
  • Contribute to project initiatives, process improvements, and knowledge sharing.
  • Provide guidance or mentoring to less experienced CRAs as appropriate.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service